QAR 0.67
(-0.89%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 292.8 Million | 144.56 Million | 327.64 Million | 188.77 Million | 144.26 Million | 308.51 Million |
Net Income | 41.51 Million | 81.94 Million | 60.25 Million | -160.08 Million | -129.65 Million | -96.91 Million |
Depreciation & Amortization | 69.04 Million | 80.9 Million | 74.94 Million | 99.12 Million | 185.95 Million | 128.69 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 145.99 Million | -103.56 Million | 128.53 Million | -5.81 Million | -145.89 Million | 72.44 Million |
Other non-cash items | 36.24 Million | 85.28 Million | 63.9 Million | 255.54 Million | 233.86 Million | 204.28 Million |
Investing Cash Flow | 122.61 Million | 18.58 Million | 12.27 Million | 15.01 Million | -22.15 Million | -45.5 Million |
Investments in PPE | -38.2 Million | -41.82 Million | -27.38 Million | -12.99 Million | -32.34 Million | -41.32 Million |
Acquisitions | 8.42 Million | 3.55 Million | -2.93 Million | -1.2 Million | 1000.00 | -2.7 Million |
Investment purchases | -528 Thousand | 34.52 Thousand | 1.57 Million | -790.2 Thousand | -8.26 Million | -10.38 Million |
Sales/Maturities of investments | 152.91 Million | 17.49 Million | 30.77 Million | 18.81 Million | 15.36 Million | 9.98 Million |
Other Investing Activities | 1.00 | 39.32 Million | 10.23 Million | 11.18 Million | 3.08 Million | -1.06 Million |
Financing Cash Flow | -220.57 Million | -255.66 Million | -443.72 Million | 6.69 Million | -168.86 Million | -310.76 Million |
Debt repayment | -211.05 Million | -558.84 Million | -372.72 Million | -1.69 Million | -5.92 Million | -145.98 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -9.52 Million | 303.18 Million | -71 Million | 8.39 Million | -162.93 Million | -310.76 Million |
Accounts receivables | 171.34 Million | 77.72 Million | 123.24 Million | 80.76 Million | -78.93 Million | 18.91 Million |
Accounts payables | -11.01 Million | -31.42 Thousand | -26.11 Million | -128.3 Million | -20.52 Million | 25.73 Million |
Inventory | -22.78 Million | -83.28 Million | 56.41 Million | 68.28 Million | 68.88 Million | 78.47 Million |
Other working capital | 8.45 Million | -97.97 Million | -25.01 Million | -26.55 Million | -115.31 Million | -6.03 Million |
Cash at beginning of period | 92.81 Million | 102.47 Million | 206.28 Million | -4.2 Million | 43.4 Million | 91.15 Million |
Cash at end of period | 257.99 Million | 9.95 Million | 102.47 Million | 206.28 Million | -3.34 Million | 43.4 Million |
Capital Expenditure | -38.2 Million | -41.82 Million | -27.38 Million | -12.99 Million | -32.34 Million | -41.32 Million |
Effect of forex changes on cash | -29.65 Million | - | - | - | - | - |
Net cash flow / Change in cash | 165.18 Million | -92.51 Million | -103.81 Million | 210.48 Million | -46.75 Million | -47.75 Million |
Free Cash Flow | 254.6 Million | 102.73 Million | 300.26 Million | 175.78 Million | 111.92 Million | 267.19 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 15.44 Million | 11.33 Million | 28.53 Million | 41.51 Million | 8.43 Million | -2.39 Million |
Depreciation & Amortization | - | - | - | 69.04 Million | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | 145.99 Million | - | - |
Other non-cash items | -15.44 Million | -11.33 Million | -28.53 Million | 36.24 Million | -8.43 Million | 2.39 Million |
Investing Cash Flow | - | - | - | 122.61 Million | - | - |
Investments in PPE | - | - | - | -38.2 Million | - | - |
Acquisitions | - | - | - | 8.42 Million | - | - |
Investment purchases | - | - | - | -528 Thousand | - | - |
Sales/Maturities of investments | - | - | - | 152.91 Million | - | - |
Other Investing Activities | - | - | - | 1.00 | - | - |
Financing Cash Flow | - | - | - | -220.57 Million | - | - |
Debt repayment | - | - | - | -211.05 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | -9.52 Million | - | - |
Accounts receivables | - | - | - | 171.34 Million | - | - |
Accounts payables | - | - | - | -11.01 Million | - | - |
Inventory | - | - | - | -22.78 Million | - | - |
Other working capital | - | - | - | 8.45 Million | - | - |
Cash at beginning of period | - | - | 167.02 Million | 92.81 Million | 101.74 Million | 72.04 Million |
Cash at end of period | - | - | 257.99 Million | 257.99 Million | 167.02 Million | 101.74 Million |
Capital Expenditure | - | - | - | -38.2 Million | - | - |
Effect of forex changes on cash | - | - | - | -29.65 Million | - | - |
Net cash flow / Change in cash | - | - | 90.97 Million | 165.18 Million | 65.27 Million | 29.69 Million |
Free Cash Flow | - | - | - | 254.6 Million | - | - |
LUMAXIND
CGTX
FMK
UCB
1578
CYDVF